Paper19711978
Platinum drug distribution in cancer cells and tumors.
Klein AV and 1 other. Chem Rev, 2009. Cited by 223 papers, by iCite.
Cite this record
ConductScience Library. Platinum drug distribution in cancer cells and tumors. Papers, record 19711978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19711978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Platinum | Major topic |
| Animals | |
| Humans | |
| Models, Biological |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 223 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41787885 | Molecular Dynamics Simulation of Passive Diffusion across a Human Breast Cancer Cell Membrane Model. Comparison between Cisplatin and Its Pt(IV) Derivatives. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/41787885 | PubMed |
| 40625908 | Recent progress in stimuli-activable metallo-prodrugs for cancer therapy. | Smart Mol | 2024 | https://conductscience.org/library/papers/40625908 | PubMed |
| 40489661 | Studying Noncovalent Interactions in Molecular Systems with Machine Learning. | Chem Rev | 2025 | https://conductscience.org/library/papers/40489661 | PubMed |
| 40315445 | Protoporphyrin IX-Derived Ruthenium(II) Complexes for Photodynamic Therapy in Gastric Cancer Cells. | Inorg Chem | 2025 | https://conductscience.org/library/papers/40315445 | PubMed |
| 39878587 | Exploring the Structure-Activity Relationships of Albumin-Targeted Picoplatin-Based Platinum(IV) Prodrugs. | Inorg Chem | 2025 | https://conductscience.org/library/papers/39878587 | PubMed |
| 39031237 | An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects. | J Fluoresc | 2025 | https://conductscience.org/library/papers/39031237 | PubMed |
| 39025943 | Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours. | Nat Biomed Eng | 2024 | https://conductscience.org/library/papers/39025943 | PubMed |
| 38801468 | Binding energies and hydrogen bonds effects on DNA-cisplatin interactions: a DFT-xTB study. | J Mol Model | 2024 | https://conductscience.org/library/papers/38801468 | PubMed |
| 38613713 | Synthesis and Characterization of Zn(II) Complex of 4-chloro-2-(((2-phenoxyphenyl)imino)methyl)phenol and its Biological Efficacies: DNA Interaction, ADMET, DFT and Molecular Docking Study. | J Fluoresc | 2025 | https://conductscience.org/library/papers/38613713 | PubMed |
| 37687231 | Oxidation of the Platinum(II) Anticancer Agent [Pt{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] to Platinum(IV) Complexes by Hydrogen Peroxide. | Molecules | 2023 | https://conductscience.org/library/papers/37687231 | PubMed |
| 37615895 | Study on the Interactions Between Cisplatin and Cadherin by Fluorescence Spectrometry and Atomic Force Microscopy. | J Fluoresc | 2024 | https://conductscience.org/library/papers/37615895 | PubMed |
| 37241854 | Novel Biotinylated Cu(II)-Phenanthroline Complexes: 2D and 3D Cytotoxic Activity and Mechanistic Insight. | Molecules | 2023 | https://conductscience.org/library/papers/37241854 | PubMed |
| 37083254 | Regium-π Bonds Involving Nucleobases: Theoretical Study and Biological Implications. | Inorg Chem | 2023 | https://conductscience.org/library/papers/37083254 | PubMed |
| 36457031 | Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011-2022 review. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/36457031 | PubMed |
| 36324675 | Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36324675 | PubMed |
| 36311834 | One Stone Two Birds: Redox-Sensitive Colocalized Delivery of Cisplatin and Nitric Oxide through Cascade Reactions. | JACS Au | 2022 | https://conductscience.org/library/papers/36311834 | PubMed |
| 36253861 | The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/36253861 | PubMed |
| 36080200 | Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells. | Molecules | 2022 | https://conductscience.org/library/papers/36080200 | PubMed |
| 36014491 | Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation. | Molecules | 2022 | https://conductscience.org/library/papers/36014491 | PubMed |
| 35849344 | LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/35849344 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19711978
GET https://conductscience.org/api/papers/v1/19711978/cited_by?page=2